本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Acurx Pharmaceuticals, LLC*

1.40
0.0000
盤後1.400.0036+0.26%19:56 EDT
成交量:6.47萬
成交額:9.01萬
市值:765.98萬
市盈率:-0.46
高:1.41
開:1.41
低:1.38
收:1.40
52周最高:8.34
52周最低:1.31
股本:547.13萬
流通股本:534.27萬
量比:1.16
換手率:1.21%
股息:- -
股息率:- -
每股收益(TTM):-3.0454
每股收益(LYR):-5.3153
淨資產收益率:-128.11%
總資產收益率:-55.92%
市淨率:0.94
市盈率(LYR):-0.26

資料載入中...

2022/05/11

重要事件披露

8-K - Current report
2022/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/17

重要事件披露

8-K - Current report
2022/03/16

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/16

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/11/24

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/22

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/22

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/10

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/19

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/07/06

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/07/06

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/29

重要事件披露

8-K - Current report
2021/06/22

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/22

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/11

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/06/11

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/27

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/05/26

SEC問詢函

CORRESP [Cover] - Correspondence